Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2016 Mar 2;68(2):277–286. doi: 10.1053/j.ajkd.2016.01.019

Figure 1.

Figure 1

Derivation of the study populations from the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial cohort. Abbreviation: CVD, cardiovascular disease.